HERON THERAPEUTICS, INC. /DE/ Cash
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Cash of $83.50 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets
us-gaap:Cash · last filed 2022-08-09
- 2022-06-30: Cash $83.50M.
- 2014-12-31: Cash $72.70M.
- 2014-09-30: Cash $86.21M.
- 2014-06-30: Cash $105.01M.
| Period end | Cash |
|---|---|
| 2022-06-30 | $83.50M 10-Q · filed 2022-08-09 |
| 2014-12-31 | $72.70M 10-K · filed 2015-03-13 |
| 2014-09-30 | $86.21M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $105.01M 10-Q · filed 2014-08-04 |
| 2013-12-31 | $72.29M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |